ZA87442B - Imidazo(1,2-a)quinoline derivatives,their preparation and their application in therapy - Google Patents

Imidazo(1,2-a)quinoline derivatives,their preparation and their application in therapy

Info

Publication number
ZA87442B
ZA87442B ZA87442A ZA87442A ZA87442B ZA 87442 B ZA87442 B ZA 87442B ZA 87442 A ZA87442 A ZA 87442A ZA 87442 A ZA87442 A ZA 87442A ZA 87442 B ZA87442 B ZA 87442B
Authority
ZA
South Africa
Prior art keywords
see diagramm
compound
formula
alkylamino
alpha
Prior art date
Application number
ZA87442A
Inventor
Pascal George
Daniele De Peretti
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of ZA87442B publication Critical patent/ZA87442B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Optical Fibers, Optical Fiber Cores, And Optical Fiber Bundles (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

1. Claims for the Contracting States : BE, CH, DE, FR, GB, IT, LI, LU, NL, SE Imidazo[1,2-_a]quinoline derivatives corresponding to the formula (I) see diagramm : EP0233800,P14,F1 in which X denotes hydrogen, a halogen or a (C1-4 )alkyl, (C1-4 )-alkoxy, (C1-4 )alkylthio, methylsulphonyl, amino, (C1-4 )-alkylamino, di(C1-4 )alkylamino, nitro or trifluoroalkyl group, Y denotes hydrogen, a halogen or a methyl group at position 6, 7 or 8, and R1 and R2, taken separately, each denote hydrogen or a (C1-6 )alkyl group, or alternatively R1 and R2 together form a tetramethylene, pentamethylene, 3-methyl-3-azapentamethylene or 3-oxapentamethylene chain, as well as their addition salts which are acceptable in pharmacology. 1. Claims for the Contracting States : AT, ES, GR Process for the preparation of imidazo[1,2-_a]quinoline derivatives corresponding to the formula (I) see diagramm : EP0233800,P16,F1 in which X denotes hydrogen, a halogen or a (C1-4 )alkyl, (C1-4 )-alkoxy, (C1-4 )alkylthio, methylsulphonyl, amino, (C1-4 )-alkylamino, di(C1-4 )alkylamino, nitro or trifluoroalkyl group, Y denotes hydrogen, a halogen or a methyl group at position 6, 7 or 8, and R1 and R2, taken separately, each denote hydrogen or a (C1-6 )alkyl group, or alternatively R1 and R2 together form a tetramethylene, pentamethylene, 3-methyl-3-azapentamethylene or 3-oxapentamethylene chain, which process is characterized in that the quinoline of formula (II) see diagramm : EP0233800,P16,F2 is first subjected to the action of an alpha-bromoacetophenone bearing the substituent X defined above, in the heated state in a solvent such as methylene chloride or 1,2-dichloroethane ; an ionic compound of formula (III) see diagramm : EP0233800,P16,F3 is obtained, which is cyclized in the presence of ammonium acetate, in an acidic organic solvent such as acetic or propionic acid, at a temperature of 90 degrees C, to obtain the compound of formula (IV) see diagramm : EP0233800,P16,F4 the compound obtained (IV) is reacted with glyoxylic acid in a solvent such as acetic acid at 80 degrees C ; the alpha-hydroxy acid obtained (V) see diagramm : EP0233800,P17,F1 is acetylated using acetic anhydride in the presence of pyridine, and then converted to the alpha-acetoxyacetamide see diagramm : EP0233800,P17,F2 via the imidazolide, which is prepared in situ ; the compound (VI) is deacetylated to the alpha-hydroxyacetamide (VII) see diagramm : EP0233800,P17,F3 by treatment with potassium carbonate in ethanol ; the compound (VII) is reacted with sulphonyl chloride SOCl2 in a chlorinated solvent such as dichloromethane, to obtain the chlorinated compound (VIII) see diagramm : EP0233800,P17,F4 which is reduced using Rongalite**(r) in methylene chloride to the compound (I).
ZA87442A 1986-01-22 1987-01-21 Imidazo(1,2-a)quinoline derivatives,their preparation and their application in therapy ZA87442B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8600834A FR2593179B1 (en) 1986-01-22 1986-01-22 IMIDAZO (1,2-A) QUINOLEINS DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION

Publications (1)

Publication Number Publication Date
ZA87442B true ZA87442B (en) 1987-09-30

Family

ID=9331353

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA87442A ZA87442B (en) 1986-01-22 1987-01-21 Imidazo(1,2-a)quinoline derivatives,their preparation and their application in therapy

Country Status (18)

Country Link
EP (1) EP0233800B1 (en)
JP (1) JPS62169783A (en)
AT (1) ATE50578T1 (en)
AU (1) AU585688B2 (en)
CA (1) CA1286668C (en)
DE (1) DE3761770D1 (en)
DK (1) DK31887A (en)
ES (1) ES2014306B3 (en)
FI (1) FI85476C (en)
FR (1) FR2593179B1 (en)
GR (1) GR3000463T3 (en)
HU (1) HU194232B (en)
IE (1) IE59173B1 (en)
IL (1) IL81335A (en)
NO (1) NO164596C (en)
NZ (1) NZ219008A (en)
PT (1) PT84159B (en)
ZA (1) ZA87442B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2593180B1 (en) * 1986-01-22 1990-10-26 Synthelabo IMIDAZO (1,2-A) QUINOLEINS ACYLAMINOMETHYL-1 DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
WO1997000074A1 (en) * 1995-06-15 1997-01-03 Pharmacia & Upjohn Company USE OF IMIDAZO[1,5-a]QUINOLONES AS NEUROPROTECTIVE AGENTS
FR2759700B1 (en) * 1997-02-20 1999-03-19 Synthelabo IMIDAZO [2,1-C] [1,4] BENZOTHIAZINE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
FR2783828B1 (en) * 1998-09-29 2000-11-10 Synthelabo 5,6-DIHYDRO-4H-IMIDAZO [1,2-A] [1] BENZAZEPINE -1-ACETIC ACID DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
EP1575952B1 (en) 2002-12-18 2009-02-18 Mallinckrodt Inc. Synthesis of heteroaryl acetamides
US7498439B2 (en) * 2004-06-22 2009-03-03 Mallinckrodt Inc. Synthesis of heteroaryl acetamides from reaction mixtures having reduced water content

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2492382A1 (en) * 1980-10-22 1982-04-23 Synthelabo IMIDAZO (1,2-A) PYRIDINE DERIVATIVES, THEIR PREPARATION AND THERAPEUTIC USE THEREOF
FR2568879B1 (en) * 1984-08-07 1986-12-12 Synthelabo IMIDAZO (1,2-A) QUINOLINES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
FR2593180B1 (en) * 1986-01-22 1990-10-26 Synthelabo IMIDAZO (1,2-A) QUINOLEINS ACYLAMINOMETHYL-1 DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION

Also Published As

Publication number Publication date
HUT43063A (en) 1987-09-28
DK31887D0 (en) 1987-01-21
IE59173B1 (en) 1994-01-26
IL81335A (en) 1990-07-12
IL81335A0 (en) 1987-08-31
PT84159B (en) 1989-07-31
FI85476C (en) 1992-04-27
FI870252A0 (en) 1987-01-21
ATE50578T1 (en) 1990-03-15
FR2593179B1 (en) 1988-04-01
EP0233800A1 (en) 1987-08-26
NZ219008A (en) 1989-08-29
ES2014306B3 (en) 1990-07-01
AU6789887A (en) 1987-07-23
NO870249L (en) 1987-07-23
AU585688B2 (en) 1989-06-22
NO164596B (en) 1990-07-16
EP0233800B1 (en) 1990-02-28
HU194232B (en) 1988-01-28
DK31887A (en) 1987-07-23
NO164596C (en) 1990-10-24
JPS62169783A (en) 1987-07-25
CA1286668C (en) 1991-07-23
FI85476B (en) 1992-01-15
IE870155L (en) 1987-07-22
FR2593179A1 (en) 1987-07-24
PT84159A (en) 1987-02-01
GR3000463T3 (en) 1991-06-28
FI870252A (en) 1987-07-23
DE3761770D1 (en) 1990-04-05
NO870249D0 (en) 1987-01-21

Similar Documents

Publication Publication Date Title
US4513138A (en) Camptothecin-1-oxide derivatives
AU585688B2 (en) Imidazo``1,2-a`` quinoline derivatives, their preparation and their application in therapy
ATE53034T1 (en) PROCESS FOR THE PREPARATION OF CEPHEM COMPOUNDS.
DK162602C (en) METHOD FOR PREPARING 7-ACYLAMINO-3- (THIO-SUBSTITUTED) METHYL-3-CEPHEM-4-CARBOXYLIC ACID-1-OXIDE DERIVATIVES
DK24088A (en) METHOD AND INTERMEDIATES FOR THE PREPARATION OF THIAZOLOBENZIMIDAZOLES
KR850004758A (en) Preparation of pyrazolopyridine derivatives
DE69026638D1 (en) Process for the preparation of pyrido [1,2-a] pyrimidine derivatives
DE3760058D1 (en) 3,4-dihydro-2,5,7,8-tetramethyl-2h-1-benzopyran derivatives and processes for their preparation
JPS6425781A (en) 7-deazapurine derivative and production thereof
JPS646265A (en) Production of thiazepine derivative
KR950000699A (en) Novel quinoline carboxylic acid derivatives having 7-dihydropyrrolopyrimidine radicals and preparation methods thereof